OmegaQuant Makes Inc. 5000 List for 2nd Year in a Row & Continues to Blaze a Trail in Personalized Nutrition

August 12, 2020, Sioux Falls, SD: Inc. magazine today revealed that OmegaQuant has landed on its annual Inc. 5000 list, the most prestigious ranking of the nation’s fastest-growing private companies. The list represents a unique look at the most successful companies within the American economy’s most dynamic segment—its independent small businesses.

This is the second year in a row OmegaQuant has earned a spot on the Inc. 5000 list, ranking 2863 and experiencing 140% growth. Intuit, Zappos, Under Armour, Microsoft, Patagonia, and many other well-known names gained their first national exposure as honorees on the Inc. 5000.

“The companies on this year’s Inc. 5000 come from nearly every realm of business,” says Inc. editor-in-chief Scott Omelianuk. “From health and software to media and hospitality, the 2020 list proves that no matter the sector, incredible growth is based on the foundations of tenacity and opportunism.”

William S. Harris, PhD, founded OmegaQuant in 2009 to commercialize the Omega-3 Index Test, which measures the amount of the omega-3s EPA and DHA in the blood using a simple finger stick and one drop of blood. Omega-3s are found in fish like salmon and supplements like fish oil, and they are important for heart, brain, eye, and overall health.

And while omega-3s are very popular, most people don’t know if they are getting enough unless they measure their blood level. The Omega-3 Index test will tell you if your diet is delivering enough of the right omega-3s.

Over the last decade, OmegaQuant has grown considerably, adding more fatty acid tests to its portfolio, including its latest product, The Prenatal DHA Test. And there are more nutritional status tests in the pipeline, such as Vitamin D.

Dr. Harris has been researching fatty acids for more than 35 years and to date has published more than 300 papers on these nutrients. Since co-inventing the Omega-3 Index in 2004, it has been the focus of more than 100 research papers.

“We continue to build the evidence base for the Omega-3 Index by working with some of the most prestigious research institutions in the world. To date, we’ve worked with more than 100 of them, including the US Army, Harvard, Tufts, Columbia, Stanford, Oxford and more,” Dr. Harris said, adding, “We believe in the power of the Omega-3 Index not only to assess one’s status, but also to arm them with important information about their diet and lifestyle. The Omega-3 Index has real clinical implications, particularly for heart and brain health, and we’re proud of how well it has been received by the medical and scientific communities, as well as by individuals.”

“Receiving this award last year and now this year is further proof that we are on the right track as a business,” said Jason Polreis, CEO, OmegaQuant. “We are motivated by the intense interest from healthcare providers, brands and individuals, all of which want to use this simple, safe, convenient test to manage intake of omega-3s.”

“Personalized nutrition is not the wave of the future—it’s already here. And the Omega-3 Index is just one tool in that toolbox, which can help consumers take control of their own health and help them make informed decisions about their diet,” Polreis added.

Complete results of the Inc. 5000, including company profiles and an interactive database that can be sorted by industry, region, and other criteria, can be found at


Media Inquiries:

Becky Wright
Marketing & Communications Director, OmegaQuant

About OmegaQuant: OmegaQuant is an independent, CLIA-certified lab that offers Omega-3 Index testing to researchers, clinicians and the public and sets the standard for fatty acid testing. OmegaQuant performs fatty acid analysis in Sioux Falls, SD, for commercial and academic research collaborators, and for consumers interested in monitoring their nutritional status in both blood and breastmilk. Its goal is to offer the highest quality fatty acid analytical services to researchers and to provide simple tests of nutritional status to consumers, with the ultimate purpose of advancing the science and use of omega-3 fatty acids to improve health. Most recently, it opened an additional lab in Brisbane, Australia. It also recently received approval in the EU market and opened a lab in Scotland, officially making the Omega-3 Index an internationally accessible test.

More about Inc. and the Inc. 5000

Methodology: The 2020 Inc. 5000 is ranked according to percentage revenue growth when comparing 2016 and 2019. To qualify, companies must have been founded and generating revenue by March 31, 2016. They had to be U.S.-based, privately held, for profit, and independent—not subsidiaries or divisions of other companies—as of December 31, 2019. (Since then, a number of companies on the list have gone public or been acquired.) The minimum revenue required for 2016 is $100,000; the minimum for 2019 is $2 million. As always, Inc. reserves the right to decline applicants for subjective reasons. Companies on the Inc. 500 are featured in Inc.’s September issue. They represent the top tier of the Inc. 5000, which can be found at

About Inc. Media: The world’s most trusted business-media brand, Inc. offers entrepreneurs the knowledge, tools, connections, and community to build great companies. Its award-winning multi-platform content reaches more than 50 million people each month across a variety of channels including websites, newsletters, social media, podcasts, and print. Its prestigious Inc. 5000 list, produced every year since 1982, analyzes company data to recognize the fastest-growing privately held businesses in the United States. The global recognition that comes with inclusion in the 5000 gives the founders of the best businesses an opportunity to engage with an exclusive community of their peers, and the credibility that helps them drive sales and recruit talent. The associated Inc. 5000 Conference is part of a highly acclaimed portfolio of bespoke events produced by Inc. For more information, visit


These statements have not been evaluated by the Food and Drug Administration. This test is not intended to diagnose, treat, cure, prevent or mitigate any disease. This site does not offer medical advice, and nothing contained herein is intended to establish a doctor/patient relationship. OmegaQuant, LLC is regulated under the Clinical Laboratory improvement Amendments of 1988 (CLIA) and is qualified to perform high complexity clinical testing. The performance characteristics of this test were determined by OmegaQuant, LLC. It has not been cleared or approved by the U.S. Food and Drug Administration.